ANKRD34C: Regulation of Actinin and Cellular Processes (G390616)

Target Name: ANKRD34C

NCBI ID: G390616

ANKRD34C

Other Name(s): AN34C_HUMAN | ankyrin repeat domain 34C | Ankyrin repeat domain-containing protein 34C | Ankyrin repeat domain 34C | Ankyrin repeat domain protein 34C

ANKRD34C: Regulation of Actinin and Cellular Processes

ANKRD34C (AN34C_HUMAN) is a protein that is expressed in various tissues of the human body, including the brain, heart, kidneys, and liver. It is a member of the ANKRD3 family of proteins, which are involved in the regulation of actinin, a protein that is involved in the structure and function of cells.

The ANKRD34C protein is composed of 1,262 amino acids and has a calculated molecular weight of 19.9 kDa. It is expressed in a variety of tissues and cells in the body, including the brain, where it is highly expressed in the neuro cortices and is also found in the cerebellum, basal ganglia, and spinal cord. It is also expressed in the heart, kidneys, and liver, where it is expressed at low levels.

The ANKRD34C protein is involved in the regulation of actinin, which is a protein that is involved in the structure and function of cells. This protein is thought to be involved in the regulation of various cellular processes, including cell adhesion, migration, and signaling.

One of the key functions of the ANKRD34C protein is its role in the regulation of actinin. This protein is known to be involved in the regulation of the level of actinin in various cells, including neurons and glial cells. It is thought to do this by interacting with the protein tyrosine kinase (TK), which is a enzyme that is involved in the regulation of actinin.

The ANKRD34C protein is also involved in the regulation of other proteins that are involved in the regulation of actinin. For example, it is known to be involved in the regulation of the level of the protein p21, which is a known to play a role in the regulation of actinin.

In addition to its role in the regulation of actinin, the ANKRD34C protein is also involved in the regulation of various cellular processes that are important for the survival and function of cells. For example, it is known to be involved in the regulation of the level of the protein Bad, which is a known to play a role in the regulation of cell death.

The ANKRD34C protein is also involved in the regulation of the immune response, which is an important process for the regulation of the health and function of the body. For example, it is known to be involved in the regulation of the level of the protein PD-L1, which is a known to play a role in the regulation of immune responses.

The ANKRD34C protein is also involved in the regulation of the production of various signaling molecules, which are important for the communication and regulation of cellular processes. For example, it is known to be involved in the regulation of the production of the proteinCREB-p2, which is a known to play a role in the regulation of gene expression.

In conclusion, ANKRD34C (AN34C_HUMAN) is a protein that is involved in the regulation of various cellular processes that are important for the survival and function of cells. It is expressed in a variety of tissues and cells in the body and is thought to play a role in the regulation of actinin, the regulation of the immune response, and the regulation of the production of various signaling molecules. As a result, ANKRD34C is a potential drug target and a biomarker for various diseases, including cancer, neurodegenerative diseases, and autoimmune diseases.

Protein Name: Ankyrin Repeat Domain 34C

The "ANKRD34C Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ANKRD34C comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets